Eltrombopag Use in Patients With Chronic Myelomonocytic Leukemia (CMML): A Cautionary Tale.
CONCLUSION: Further clinical studies are needed to identify patients with CMML who will benefit from this treatment.
PMID: 27521328 [PubMed - as supplied by publisher]
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Ramadan H, Duong VH, Al Ali N, Padron E, Zhang L, Lancet JE, List AF, Komrokji RS Tags: Clin Lymphoma Myeloma Leuk Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Chronic Leukemia | Clinical Trials | Hematology | Leukemia | Lymphoma | Myelodysplastic Syndrome | Myeloma | Study | Thrombocytopenia